Lifebit powers the federated infrastructure behind national-scale biomedical research. Our platform enables pharma, biobanks, and governments to analyze the world's most sensitive health data — without the data ever leaving its source. Genomics England runs on Lifebit.
So do ten of the world's largest biobanks, and research programs spanning the UK, US, and Asia.
We built the federated Trusted Research Environment (TRE) from first principles around the ONS Five Safes framework: data stays at source, sovereignty stays with the data controller, and every output passes through an airlock.
It's what makes population-scale genomics, federated multi-omic analysis, and cross-border biomedical AI possible without compromising patient trust. For the pharma companies accelerating discovery. For the biobanks safeguarding a generation of consented data.
